期刊文献+

乌司他丁在肝移植围手术期中的应用 被引量:7

THE PERI-OPERATIVE USE OF UTI IN THE LIVER TRANSPLANTATION
下载PDF
导出
摘要 目的 :研究乌司他丁 (UTI)在肝移植手术期中的作用。方法 :在 1999年 8月~ 2 0 0 0年 12月对 2 9例各种终末期肝病施行 31例次肝移植 ,本组术前 3天及术后 7d分别应用UTI。对照组为 1995年以来施行的 36例未用UTI肝移植组。两组分别观察血、尿淀粉酶、HCT、IL - 2、BUN、Cr、ARDS、胸水、腹水等指标。结果 :用药组较对照组术后近期各种并发症、病死率明显减少。结论 :UTI具有抗手术侵袭、减少炎性介质释放、稳定细胞膜等效应 ,并因而减少肝移植术后并发症及病死率。 Objective:To study the peri-operative effect of UTI in the liver transplantation. Methods:UTI was administrated peri-operatively, 3 days prior to and 7 days posterior to the day of the operation to 29 cases of the end-stage live diseases who had 31 liver transplantations from August 1999 to December 2000. The control group includes 36 liver transplantation cases since 1995, to which UTI was not administrated. Both groups were observed respectively for blood and urine amylase, HCT, IL-2, BUN,Blood Cr, ARDS, pleural effusion, ascites, etc. Result:Complications and mortality shortly after operation were significantly reduced, compared with the control group.Conclusion:UTI can reduce the release of the inflammatory mediators, stable the cell membrane, and therefore help the patients resist the attack of the operation and reduce the complications and mortality of the liver transplantation.
出处 《中国现代医学杂志》 CAS CSCD 2002年第22期1-2,5,共3页 China Journal of Modern Medicine
关键词 围手术期 肝移植 终末期肝病 马司他汀 UTI Liver Transplantation UTI Peri-operative Effect
  • 相关文献

参考文献3

  • 1平山亮夫.乌司他丁(MR-20)治疗胰腺炎的临床效果[J].新药与临床,1984,33(1):23-32.
  • 2本间达二.乌司他丁治疗胰腺炎的经验[J].基础与临床,1983,17(12):259-263.
  • 3林晃纪.乌司他丁对失血所至低血压患者的临床作用研究[J].急救医学,1988,12(2):187-192.

共引文献1

同被引文献55

  • 1旷昕,黄艳.乌司他丁对体外循环心脏病人血浆TNF-a,IL-6和IL-8的影响[J].中国医学工程,2004,12(5):26-28. 被引量:19
  • 2周敬敏,李汉忠.肾移植急性排斥反应的早期诊断[J].国际移植与血液净化杂志,2006,4(2):17-21. 被引量:12
  • 3HUO Guo-dong CAI Shao-xi CHEN Bo CHEN Ying-hua.Effects of serum of the rats ventilated with high tidal volume on endothelial cell permeability and therapeutic effects of ulinastatin[J].Chinese Medical Journal,2006(16):1374-1380. 被引量:7
  • 4Fries E,Blom AM.Bikunin-not just a plasma proteinase inhibitor[J].Int J Biochem Cell Biol,2000,32(2):125-137.
  • 5Tsujino T;Komatsu Y;Isayama H et al.Ulinastatin for pancreatitis af-ter endoscopic retrograde cholangiopancreatography:a randomized,controlled trial[J].Clin Gastroenterol Hepatol,2005,3(4):376-383.
  • 6Ohwada M;Watanabe N;Maeda M et al.New endoscopic treatmentfor chronic pancreatitis,using contrast media containing ulinastatinand prednisolone[J].Gastroenterol,1997,32(2):216-221.
  • 7Uemura K;Murakami Y;Hayashidani Y et al.Randomized clinicaltrial to assess the efficacy of ulinastatin for postoperative pancreatitisfollowing pancreaticoduo-denectomy[J].J Surg Oncol,2008,98(5):309-313.
  • 8Li FR;Qiu L;Yang XF et al.The protective effects of ulinastatin andadenosine triphosphate on islet function during islet isolation and afterislet transplantation[J].Pancreas,2009,38(2):227-230.
  • 9Okuhama Y,Shiraishi M,Higa T,et al.Protective effects of ulinasta-tin agaist ischemia-reperfusion injury[J].J Surg Res,1999,82(1):34-42.
  • 10Ueki M,Yokono S,Taie S,et al.Effects of ulinastatin on postoperativerenal function in hepatectomized patients with liver cirrhosis[J].Ma-sui,1997,46:251-255.

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部